Approval · Notice of Compliance 2408 · 2001
PRIORIX: Notice of Compliance 2408
Issued October 12, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2408
- Date
- October 12, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Active immunizing agent against infection by measles, mumps and rubella
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRIORIX | 02239208 | Marketed |
Medicinal ingredients
- WATER 0.5 ML per 0.5ML
- MEASLES VIRUS LIVE ATTENUATED (SCHWARZ STRAIN) 1,000 UNIT per 0.5ML
- MUMPS VIRUS VACCINE LIVE ATTENUATED JERYL LYNN STRAIN 10,000 UNIT per 0.5ML
- RUBELLA VIRUS VACCINE LIVE ATTENUATED WISTAR RA27/3 STRAIN 1,000 UNIT per 0.5ML